Monte Rosa Therapeutics, Inc. (GLUE) reported Q1 Revenue
Tweet
Share
E-mailGet Alerts GLUE Hot Sheet
Join SI Premium – FREE
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) reported Q1 Revenue for the quarter came in at $4.21 million versus the consensus estimate of $13.57 million.
For earnings history and earnings-related data on Monte Rosa Therapeutics, Inc. (GLUE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Reinstates Zoom Video (ZM) at Buy
- Needham on Klarna (KLAR): 'Shares Back to the Penalty Box'
- CXApp acquires Australian firm EngineRoom in June 2026 deal
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
